Author:
Ju Wen-Zheng,Zhao Yang,Liu Fang,Wu Ting,Zhang Jun,Liu Shi-Jia,Zhou Ling,Dai Guo-Liang,Xiong Ning-Ning,Fang Zhu-Yuan
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference23 articles.
1. Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes;Chai;J. Ethnopharmacol.,2013
2. Inhibition of platelet activation and endothelial cell injury by polyphenolic compounds isolated from Lonicera japonica Thunb;Chang;Prostaglandins Leukot Essent Fatty Acids,1992
3. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration;Chen;Drug Metab. Dispos.,2006
4. FDA, 2005. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). http://www.fda.gov/downloads/Drugs/Guidances/UCM078932.pdf.
5. FDA, 2013. Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献